Literature DB >> 28629554

Emphysema quantification and lung volumetry in chest X-ray equivalent ultralow dose CT - Intra-individual comparison with standard dose CT.

Michael Messerli1, Thorsten Ottilinger2, René Warschkow3, Sebastian Leschka4, Hatem Alkadhi5, Simon Wildermuth2, Ralf W Bauer2.   

Abstract

OBJECTIVES: To determine whether ultralow dose chest CT with tin filtration can be used for emphysema quantification and lung volumetry and to assess differences in emphysema measurements and lung volume between standard dose and ultralow dose CT scans using advanced modeled iterative reconstruction (ADMIRE).
METHODS: 84 consecutive patients from a prospective, IRB-approved single-center study were included and underwent clinically indicated standard dose chest CT (1.7±0.6mSv) and additional single-energy ultralow dose CT (0.14±0.01mSv) at 100kV and fixed tube current at 70mAs with tin filtration in the same session. Forty of the 84 patients (48%) had no emphysema, 44 (52%) had emphysema. One radiologist performed fully automated software-based pulmonary emphysema quantification and lung volumetry of standard and ultralow dose CT with different levels of ADMIRE. Friedman test and Wilcoxon rank sum test were used for multiple comparison of emphysema and lung volume. Lung volumes were compared using the concordance correlation coefficient.
RESULTS: The median low-attenuation areas (LAA) using filtered back projection (FBP) in standard dose was 4.4% and decreased to 2.6%, 2.1% and 1.8% using ADMIRE 3, 4, and 5, respectively. The median values of LAA in ultralow dose CT were 5.7%, 4.1% and 2.4% for ADMIRE 3, 4, and 5, respectively. There was no statistically significant difference between LAA in standard dose CT using FBP and ultralow dose using ADMIRE 4 (p=0.358) as well as in standard dose CT using ADMIRE 3 and ultralow dose using ADMIRE 5 (p=0.966). In comparison with standard dose FBP the concordance correlation coefficients of lung volumetry were 1.000, 0.999, and 0.999 for ADMIRE 3, 4, and 5 in standard dose, and 0.972 for ADMIRE 3, 4 and 5 in ultralow dose CT.
CONCLUSIONS: Ultralow dose CT at chest X-ray equivalent dose levels allows for lung volumetry as well as detection and quantification of emphysema. However, longitudinal emphysema analyses should be performed with the same scan protocol and reconstruction algorithms for reproducibility.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Computed tomography; Emphysema; Iterative reconstruction; Radiation dose; Ultralow dose

Mesh:

Year:  2017        PMID: 28629554     DOI: 10.1016/j.ejrad.2017.03.003

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  12 in total

1.  Feasibility of low-dose CT with spectral shaping and third-generation iterative reconstruction in evaluating interstitial lung diseases associated with connective tissue disease: an intra-individual comparison study.

Authors:  Xiaoli Xu; Xin Sui; Lan Song; Yao Huang; Yingqian Ge; Zhengyu Jin; Wei Song
Journal:  Eur Radiol       Date:  2019-02-08       Impact factor: 5.315

2.  Diagnostic accuracy of chest X-ray dose-equivalent CT for assessing calcified atherosclerotic burden of the thoracic aorta.

Authors:  Michael Messerli; Andreas A Giannopoulos; Sebastian Leschka; René Warschkow; Simon Wildermuth; Lukas Hechelhammer; Ralf W Bauer
Journal:  Br J Radiol       Date:  2017-10-03       Impact factor: 3.039

3.  Chest CT Scan at Radiation Dose of a Posteroanterior and Lateral Chest Radiograph Series: A Proof of Principle in Lymphangioleiomyomatosis.

Authors:  Eileen Hu-Wang; John L Schuzer; Shirley Rollison; Eric S Leifer; Chloe Steveson; Vissaagan Gopalakrishnan; Jianhua Yao; Tania Machado; Amanda M Jones; Patricia Julien-Williams; Joel Moss; Marcus Y Chen
Journal:  Chest       Date:  2018-10-03       Impact factor: 9.410

4.  Potential for dose reduction in CT emphysema densitometry with post-scan noise reduction: a phantom study.

Authors:  Hendrik Joost Wisselink; Gert Jan Pelgrim; Mieneke Rook; Maarten van den Berge; Kees Slump; Yeshu Nagaraj; Peter van Ooijen; Matthijs Oudkerk; Rozemarijn Vliegenthart
Journal:  Br J Radiol       Date:  2019-11-28       Impact factor: 3.039

5.  Unilateral Chronic Lung Allograft Dysfunction Assessed by Biphasic Computed Tomographic Volumetry in Bilateral Living-donor Lobar Lung Transplantation.

Authors:  Masao Saito; Toyofumi F Chen-Yoshikawa; Yuji Nakamoto; Hidenao Kayawake; Junko Tokuno; Satoshi Ueda; Hiroya Yamagishi; Fumiaki Gochi; Ryo Okabe; Akihiro Takahagi; Masatsugu Hamaji; Hideki Motoyama; Akihiro Aoyama; Hiroshi Date
Journal:  Transplant Direct       Date:  2018-10-12

6.  Emphysema quantification using chest CT: influence of radiation dose reduction and reconstruction technique.

Authors:  Annemarie M den Harder; Erwin de Boer; Suzanne J Lagerweij; Martijn F Boomsma; Arnold M R Schilham; Martin J Willemink; Julien Milles; Tim Leiner; Ricardo P J Budde; Pim A de Jong
Journal:  Eur Radiol Exp       Date:  2018-11-07

7.  Feasibility of bronchial wall quantification in low- and ultralow-dose third-generation dual-source CT: An ex vivo lung study.

Authors:  Lin Zhang; Gert Jan Pelgrim; Jing Yan; Hao Zhang; Rozemarijn Vliegenthart; Xueqian Xie
Journal:  J Appl Clin Med Phys       Date:  2020-09-29       Impact factor: 2.102

Review 8.  Advances in imaging for lung emphysema.

Authors:  Katharina Martini; Thomas Frauenfelder
Journal:  Ann Transl Med       Date:  2020-11

9.  Pelvic bone CT: can tin-filtered ultra-low-dose CT and virtual radiographs be used as alternative for standard CT and digital radiographs?

Authors:  Christoph Stern; Stefan Sommer; Christoph Germann; Julien Galley; Christian W A Pfirrmann; Benjamin Fritz; Reto Sutter
Journal:  Eur Radiol       Date:  2021-03-12       Impact factor: 5.315

10.  Improved precision of noise estimation in CT with a volume-based approach.

Authors:  Hendrik Joost Wisselink; Gert Jan Pelgrim; Mieneke Rook; Ivan Dudurych; Maarten van den Berge; Geertruida H de Bock; Rozemarijn Vliegenthart
Journal:  Eur Radiol Exp       Date:  2021-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.